Entera Bio Reports Q1 2024 Financial Results and Provides Business Updates
Provided By GlobeNewswire
Last update: May 10, 2024
JERUSALEM, May 10, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins, today reported financial results and key business updates for the quarter ended March 31, 2024.
